Revolutionary Imaging Clarix Imaging offers a unique true 3D CT breast specimen imaging system (VSI-360) that provides unprecedented intraoperative margin visualization, presenting a compelling differentiator for surgical centers seeking precision and reduced reoperation rates.

Targeted Market Fit Primary customers are breast surgeons and radiologists performing lumpectomies, with an FDA-cleared solution that integrates into the operating room, suggesting opportunities in hospitals, cancer centers, and academic medical centers pursuing advanced intraoperative imaging.

Funding Momentum Recent $10M funding from kineo finance signals investor confidence and financial runway to scale sales efforts, expand clinical adoption, and accelerate trials or pilots with key oncology and surgical departments.

Growth Potential Small-to-mid sized team (11-50 employees) and revenue in the lower multi-millions indicate an opportunity to target efficiency-focused facilities and early adopters who can scale with reference sites as the product matures.

Digital & Partnerships Adopted tech stack and B2B marketing tools (LinkedIn Ads, HubSpot, Salesforce) enable targeted outbound campaigns, partner programs, and ROI-driven demand generation to accelerate clinician adoption and expand footprint across regions.